Sort
82,697 grants matching “vaccine development”
A Novel, Multi-compartment Intravaginal Ring for Prevention of Genital Herpes and Unintended Pregnancy
$828,713Marc Michael Baum · Oak Crest Institute Of Science · R01 · FY2025 · AI
Harnessing oral mucosa vaccination to drive protective HIV antibody responses
$828,617Donald L Sodora · Seattle Children'S Hospital · R01 · FY2019 · DE
Immune Correlates of Protection from TB
$828,491Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2017 · AI
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
$828,473David M Wilson · University Of California, San Francisco · R01 · FY2021 · AI
The effect of HIV exposure and infection on immunity to TB in children
$828,368Grace C John-Stewart · University Of Washington · R01 · FY2019 · AI
Development of an effective therapy against post-exposure Anthrax
$828,365Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2009 · AI
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$828,290Smita S Patel · Rbhs-Robert Wood Johnson Medical School · R35 · FY2022 · GM
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$828,290Smita S Patel · Rutgers Biomedical And Health Sciences · R35 · FY2023 · GM
Core--Animal model
$828,261Thomas W North · J. David Gladstone Institutes · P01 · FY2008 · AI
Structure and Dynamics of the SARS-CoV-2 Spike Protein
$828,211Walther H Mothes · Yale University · R01 · FY2022 · AI
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
$828,185Sallie R. Permar · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Allogeneic glioma vaccine using TGF-beta knockouts
$828,132Habib Fakhrai · Novarx Corporation · R44 · FY2009 · CA
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$828,114Gary Fanger · Rise Therapeutics, Llc · R44 · FY2023 · CA
Temporal Phenotypes and Risk Models for the Post-COVID Syndrome and its sub-types
$828,065Hossein Estiri · Massachusetts General Hospital · R01 · FY2022 · AI
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$828,047Smita S Patel · Rutgers Biomedical And Health Sciences · R35 · FY2025 · GM
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$828,047Smita S Patel · Rutgers Biomedical And Health Sciences · R35 · FY2024 · GM
Developmental Projects
$828,037Dennis L. Kasper · Harvard Medical School · U54 · FY2012 · AI
Antibody Responses in Aging SIV Infected Monkeys
$827,888Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2015 · AI
Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities
$827,788Charles T Roberts · Oregon Health & Science University · R01 · FY2020 · DK
Early Events in Mucosal SIV Pathogenesis
$827,743Ronald S. Veazey · Tulane University Of Louisiana · R01 · FY2009 · AI
Inhibitors and Probes of HIV-1 Cell Fusion
$827,494Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Inhibitors and Probes of HIV-1 Cell Fusion
$827,493Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Mechanistic studies of nucleic acid enzymes involved in DNA replication, transcription, and innate immunity
$827,460Smita S Patel · Rbhs-Robert Wood Johnson Medical School · R35 · FY2021 · GM
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$827,328Afamefuna Okoye · Oregon Health & Science University · R01 · FY2024 · AI
CAREER: Decoding the Code of Glycan-Collectin Interactions: Computational Engineering of Surfactant Proteins for Tailored Glycan Recognition
$827,316Mona S Minkara · Northeastern University · · FY2024 · ENG